Navigation Links
WuXi PharmaTech Announces Third-Quarter 2011 Results
Date:11/10/2011

SHANGHAI, Nov. 10, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the third quarter of 2011.

Highlights

  • Third-Quarter 2011 Net Revenues Increased 24.0% Year Over Year to $104.0 Million
  • Manufacturing Services Net Revenues Grew 183.8% Year Over Year to $20.1 Million
  • Laboratory Services Net Revenues Grew 9.2% Year Over Year to $83.9 Million
  • China-Based Laboratory Services Net Revenues Increased 10.7% Year Over Year to $63.2 Million
  • GAAP Operating Income Increased 15.8% Year Over Year to $22.2 Million
  • Non-GAAP Operating Income Increased 10.1% Year Over Year to $24.9 Million
  • GAAP Diluted Earnings Per ADS Declined 53.8% Year Over Year to 27 Cents Due to Inclusion in the Prior-Year Results of a Termination Fee Relating to the Proposed Transaction with Charles River Laboratories and an Increase in the Effective Tax Rate
  • Non-GAAP Diluted Earnings Per ADS Increased 2.6% Year Over Year to 31 Cents Due to an Increase in the Effective Tax Rate
  • WuXi Refines Its Full-Year 2011 Guidance
  • Board Member Jeff Leng Elected to Audit Committee

  • Management Comment"WuXi achieved another solid quarter, driven by particularly strong revenue performances in Manufacturing Services, integrated medicinal chemistry, DMPK/ADME, toxicology, formulation, and analytical and bioanalytical services," said Dr. Ge Li, Chairman and Chief Executive Officer. "We exceeded our revenue guidance and met our operating-margin guidance for the quarter. We are on track to achieve full-year 2011 revenues of $402 to $406 million, GAAP operating margin of about 21%, and non-GAAP o
    '/>"/>

    SOURCE WuXi PharmaTech (Cayman) Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related biology technology :

    1. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
    2. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
    3. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
    4. WuXi PharmaTech Appoints Jeff Leng to Its Board of Directors
    5. WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
    6. WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008
    7. WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
    8. WuXi PharmaTech Announces Third Quarter 2008 Results
    9. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
    10. WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
    11. Pharmatech 2.0: Introducing Pharmatech Oncology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... 2014 Lyme Research Alliance ... disease research at universities, today announced the awarding of ... identification, treatment and cure for Lyme and other tick-borne ... most applications in its history—over 20 grant proposals—a 100 ... were pleased to receive so many solid applications from ...
    (Date:9/30/2014)... On September 11, Pharma IQ conducted an ... of a session that he will lead on “Stem Cells” ... February 17-18, 2015 in London. In the interview posted ... Sherley to respond to several questions on the current state ... stem cell toxicity, and future trends in the use of ...
    (Date:9/30/2014)... 30, 2014 Back in the 1970’s, many ... feet. per employee, which included space for circulation and file ... Jeff Howell, partner at Nidea Corporate Real Estate / ... “By the year 2000, however, 250 square feet per ... number come down to 175 to 225 square feet, and ...
    (Date:9/29/2014)... forefront of diagnostics today, with imaging techniques like ... and NMR (nuclear magnetic resonance) increasing steeply over ... image resolution and quality still limit these techniques ... solution is hyperpolarization, which involves injecting the patient ... following the distribution and fate of specific molecules ...
    Breaking Biology Technology:Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4ITRA Global Reports on How Companies Are Squeezing More Employees into Less Office Space 2ITRA Global Reports on How Companies Are Squeezing More Employees into Less Office Space 3A safer approach for diagnostic medical imaging 2A safer approach for diagnostic medical imaging 3
    ... Inc. (NASDAQ: CYNO ) today announced financial results for ... for the first quarter of 2011 increased 16 percent to $21.9 ... Net loss for the first quarter of 2011 was $1.9 million, ... loss of $2.8 million, or $0.22 per basic and diluted share, ...
    ... 3, 2011 Answering the need for global, site-focused ... the patient enrollment industry, announces the expansion of its ... a local, site-centric level. "The extension of ... allow us to assist sponsors with their global patient ...
    ... MOUNTAIN VIEW, Calif., May 3, 2011 MAP Pharmaceuticals, Inc. ... the first quarter ended March 31, 2011. The ... was $17.6 million compared to a net loss of $14.1 ... the first quarter ended March 31, 2011 was related primarily ...
    Cached Biology Technology:Cynosure Reports Financial Results for the First Quarter of 2011 2Cynosure Reports Financial Results for the First Quarter of 2011 3Cynosure Reports Financial Results for the First Quarter of 2011 4Cynosure Reports Financial Results for the First Quarter of 2011 5Cynosure Reports Financial Results for the First Quarter of 2011 6Clinical Site Services Expands to Provide Global Patient Enrollment Services to Rest-of-World 2MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results 2MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results 3MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results 4MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results 5
    (Date:9/29/2014)... Monday, September 29: Between 1970 and 2010 populations ... the globe dropped 52 percent, says the 2014 ... Fund (WWF). This biodiversity loss occurs disproportionately in ... of high-income countries. , In addition to the ... point to other warning signs about the overall ...
    (Date:9/29/2014)... children at home should use ventilation when cooking with ... recommending, after a new study showed an association between ... chronic bronchitis. , "In homes where a gas stove ... wheezing is higher than in homes where a gas ... associate professor in the College of Public Health and ...
    (Date:9/29/2014)... a bad rap, and understandably so. The grain-of-rice-sized insects ... millions of acres in the Western U.S. and Canada ... popular belief, these pests may not be to blame ... swept through the region. Instead, weather and topography play ... than these bark-boring beetles. , New research led by ...
    Breaking Biology News(10 mins):Half of global wildlife lost, says new WWF report 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 2Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 4
    ... The advice and treatment given to patients with vertebral ... the Sahlgrenska Academy, University of Gothenburg, Sweden, shows that ... year after the fracture. Vertebral compression fracture ... spine such that its height is decreased. Approximately 15,000 ...
    ... Cambridge, MA --- The McGovern Institute for Brain Research ... Scolnick Prize in Neuroscience to Jeremy Nathans, a Howard ... and genetics, neuroscience, and opthalmology at Johns Hopkins University ... the Scolnick Prize lecture entitled "The Evolution of Trichromatic ...
    ... 23, 2009) The Wildlife Conservation Society announced today ... Africa are unusually resilient to climate change due to ... WCS announced the results of the study at ... this week in Phuket, Thailand. The study, published ...
    Cached Biology News:Poor treatment for common vertebral compression fractures 2MIT: Jeremy Nathans to deliver Scolnick Prize lecture 2'Super reefs' fend off climate change, study says 2
    Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
    Applications: Epitope mapping, Mapping protein-protein contacts, Identification of enzyme substrates/inhibitors, Identification of receptor agonists/antagonists...
    Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
    ... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
    Biology Products: